- Home
- PRAX vs CCBG Comparison
PRAX vs CCBG Comparison
Compare PRAX & CCBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- CCBG
- Stock Information
- Founded
- PRAX 2015
- CCBG 1895
- Country
- PRAX United States
- CCBG United States
- Employees
- PRAX N/A
- CCBG N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- CCBG Major Banks
- Sector
- PRAX Health Care
- CCBG Finance
- Exchange
- PRAX Nasdaq
- CCBG Nasdaq
- Market Cap
- PRAX 599.7M
- CCBG 647.6M
- IPO Year
- PRAX 2020
- CCBG N/A
- Fundamental
- Price
- PRAX $42.34
- CCBG $36.90
- Analyst Decision
- PRAX Strong Buy
- CCBG Buy
- Analyst Count
- PRAX 11
- CCBG 2
- Target Price
- PRAX $114.73
- CCBG $39.00
- AVG Volume (30 Days)
- PRAX 279.7K
- CCBG 27.2K
- Earning Date
- PRAX 08-12-2025
- CCBG 07-22-2025
- Dividend Yield
- PRAX N/A
- CCBG 2.60%
- EPS Growth
- PRAX N/A
- CCBG 11.98
- EPS
- PRAX N/A
- CCBG 3.37
- Revenue
- PRAX $8,122,000.00
- CCBG $236,037,000.00
- Revenue This Year
- PRAX N/A
- CCBG $10.45
- Revenue Next Year
- PRAX $6,358.50
- CCBG $3.50
- P/E Ratio
- PRAX N/A
- CCBG $10.88
- Revenue Growth
- PRAX 270.02
- CCBG 6.63
- 52 Week Low
- PRAX $26.70
- CCBG $26.40
- 52 Week High
- PRAX $91.83
- CCBG $40.86
- Technical
- Relative Strength Index (RSI)
- PRAX 54.36
- CCBG 46.80
- Support Level
- PRAX $41.64
- CCBG $35.94
- Resistance Level
- PRAX $44.99
- CCBG $37.64
- Average True Range (ATR)
- PRAX 2.55
- CCBG 0.87
- MACD
- PRAX -0.11
- CCBG -0.16
- Stochastic Oscillator
- PRAX 51.07
- CCBG 31.68
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.